FD
4D Molecular Therapeutics, Inc.
FDMT · NASDAQ
$13.17 -3.80% (-$0.52)
1M +15.79%
Market Cap $705.2M
P/E Ratio -
Div. Yield -
ROE 41.33%
Bulios Fair Price
$11.29
14.3% downside
Trenutna cena
$13.17
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica FDMT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
51 /100
Fair P/B 1.73x
P/S 7.66x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 29.78%
Rev. growth 200.86%
FCF growth N/A
Profitability
17 /100
Weak Net margin 194.74%
Op. margin 214.24%
FCF margin 170.27%
Quality
2 /100
Poor ROE 41.33%
ROA 36.37%
Asset turnover 0.19x
Debt
100 /100
Low Current ratio 8.03x
Debt/Equity 0.10x
Net debt/EBITDA N/A
Stability
27 /100
Unstable Rev. volatility 132,769.82%
EPS volatility 19.39%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o FDMT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David H. Kirn
Employees
196
Headquarters
EmeryVille
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report